An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
Lin Yang, Qiuling Zhao, Ting Chen, Wenbin Liu, Xiuliang Qiu, Jincan Chen, Shengqiang Huang, Ruyi Huang, Liangliang Dong
Topics & Concepts
ImmunotherapyCancer researchLymphomaCancer immunotherapyBiologyImmune systemT cellImmunologyMedicineImmune Cell Function and InteractionLymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers